Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: January 31, 2023

Drug Sales Trends for GIANVI

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Payment Methods and Pharmacy Types for GIANVI (2019)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
INSIDE ANOTHER STORE	$17,334,797
INSIDE HMO/CLINIC/HOSPITAL	$1,384,895
[disabled in preview]	$42,714,605
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
INSIDE ANOTHER STORE	269,042
INSIDE HMO/CLINIC/HOSPITAL	17,828
[disabled in preview]	696,473
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$4,398,081
PRIVATE INSURANCE	$39,275,953
[disabled in preview]	$17,760,263
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for GIANVI

Drug Units Sold Trends for GIANVI

Annual Sales Revenues and Units Sold for GIANVI

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Try it Free
Drug Name	Revenues (USD)	Units	Year
GIANVI	See Plans and Pricing	See Plans and Pricing	2019
GIANVI	See Plans and Pricing	See Plans and Pricing	2018
GIANVI	See Plans and Pricing	See Plans and Pricing	2017
GIANVI	See Plans and Pricing	See Plans and Pricing	2016
GIANVI	See Plans and Pricing	See Plans and Pricing	2015
GIANVI	See Plans and Pricing	See Plans and Pricing	2014
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Mallinckrodt

Johnson and Johnson

Merck

Express Scripts

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.